Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL a two-year follow-up study

Stroke

Volumn 36, Issue 12, 2005, Pages 2559-2565

  Holtmannspötter, Markus ^a   Peters, Nils ^a   Opherk, Christian ^a   Martin, Daniel ^a   Herzog, Jürgen ^a   Brückmann, Hartmut ^a   Sämann, Philipp ^b   Gschwendtner, Andreas ^a   Dichgans, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

CADASIL; MR histogram; MRI; Notch3; Stroke

Indexed keywords

NOTCH3 RECEPTOR;

ADULT; ALZHEIMER DISEASE; ARTICLE; CADASIL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; GENE MUTATION; HISTOGRAM; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONITORING; MULTIINFARCT DEMENTIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; RANKIN SCALE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; CROSS-SECTIONAL STUDY; MULTIVARIATE ANALYSIS; PREDICTION AND FORECASTING; PROGNOSIS; RISK FACTOR; SAMPLE SIZE;

ADULT; CADASIL; CROSS-SECTIONAL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY;

EID: 33644665455     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000189696.70989.a4     Document Type: Article

References (24)

1. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426-436.
2. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X. Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet. 1995;346:934-939.
3. Dichgans M, Mayer M, Uttner I, Bruning R, Müller-Hocker J, Rungger G, Ebke M, Klockgether T, Gasser T. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44:731-739.
4. Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 CADASIL patients. Brain. 2004;127:2533-2539.
5. Peters N, Herzog J, Opherk C, Dichgans M. A two-year clinical follow-up study in 80 CADASIL subjects: Progression patterns and implications for clinical trials. Stroke. 2004;35:1603-1608.
6. Auer DP, Putz B, Gossl C, Elbel GK, Gasser T, Dichgans M. Differential Lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology. 2001;218:443-451.
7. O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56:628-634.
8. Dichgans M, Filippi M, Bruning R, Iannucci G, Berchtenbreiter C, Minicucci L, Uttner I, Crispin A, Ludwig H, Gasser T, Yousry TA. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology. 1999;52:1361-1367.
9. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H. Diffusion tensor imaging: concepts and applications. J Magn ResonImaging. 2001;13:534-546.
10. Dichgans M, Putz B, Boos D, Auer DP. Role of subvoxel free fluid on diffusion parameters in brain tissue with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and its correlation with physical disability: histogram analysis of standard and fluid-attenuated MR diffusion. AJNR Am J Neuroradiol. 2003;24:1083-1089.
11. Molko N, Pappata S, Mangin JF, Poupon F, LeBihan D, Bousser MG, Chabriat H. Monitoring disease progression in CADASIL with diffusion magnetic resonance imaging: a study with whole brain histogram analysis. Stroke. 2002;33:2902-2908.
12. Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med. 1989;8:431-440.
13. Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med. 1999;42:515-525.
14. Bito Y, Hirata S, Yamamoto E. Optimal gradient factors for ADC measurements. Proc Intl Soc Magn Reson Med. 1995;2:913.
15. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry. 1991;54:683-688.
16. Chabriat H, Levy C, Taillia H, Iba-Zizen MT, Vahedi K, Joutel A, Tournier-Lasserve E, Bousser MG. Patterns of MRI lesions in CADASIL. Neurology. 1998;51:452-457.
17. Rovaris M, Filippi M, Calori G, Rodegher M, Campi A, Colombo B, Comi G. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol. 1997;244:266-270.
18. Cercignani M, Inglese M, Pagani E, Comi G, Filippi M. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol. 2001;22:952-958.
19. Cercignani M, Bammer R, Sormani MP, Fazekas F, Filippi M. Intersequence and inter-imaging unit variability of diffusion tensor MR imaging histogram-derived metrics of the brain in healthy volunteers. AJNR Am J Neuroradiol. 2003;24:638-643.
20. Schmidt R, Scheltens P, Erkinjuntti T, Pantoni L, Markus HS, Wallin A, Barkhof F, Fazekas F. White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology. 2004;63:139-144.
21. Chabriat H, Pappata S, Poupon C, Clark CA, Vahedi K, Poupon F, Mangin JF, Pachot-Clouard M, Jobert A, Le Bihan D, Bousser MG. Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke. 1999;30:2637-2643.
22. Molko N, Pappata S, Mangin JF, Poupon C, Vahedi K, Jobert A, LeBihan D, Bousser MG, Chabriat H. Diffusion tensor imaging study of subcortical gray matter in cadasil. Stroke. 2001;32:2049-2054.
23. O'Sullivan M, Singhal S, Charlton R, Markus HS. Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia. Neurology. 2004;62:702-707.
24. Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet. 2003;361:2046-2048.